Jubilant Pharmova Ltd share price logo

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

BSE: 530019

Small Cap

Pharma Sector

₹999.30

-29.50

(-2.87%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Jubilant Pharmova shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+20%

Searches for Jubilant Pharmova on INDmoney have increased by 20% over the last 30 days.

Investment activity on INDmoney

+49.38%

Investment activity in Jubilant Pharmova among INDmoney users has increased by 49.38% over the last 30 days.

Average holding period of indmoney investors

36 days

INDmoney investors hold Jubilant Pharmova shares for an average of 36 days.

Key Events for Jubilant Pharmova

Last Dividend Declared

₹5.00 per share, declared on 22/05/2026

View Dividend History

Jubilant Pharmova Stock Performance

as on October 1, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹980.30
    ₹1,028.60
    downward going graph

    1.90%

    Downside

    2.93%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹786.05
    ₹1,184.80
    downward going graph

    21.34%

    Downside

    18.56%

    Upside

    downward going graph

Jubilant Pharmova share price movements today

Previous Close
₹1,028.80
Open
₹1,026.00
Volume
3.36L
Upper Circuit
₹1,234.50
Lower Circuit
₹823.10
Day's Low - High
₹980.30 - ₹1,028.60
52 Week Low - High
₹786.05 - ₹1,184.80

Jubilant Pharmova Historical Returns

1 Month Return
+ 8.09 %
3 Month Return
+ 1.79 %
1 Year Return
-8.88 %
3 Year Return
+ 131.35 %
5 Year Return
+ 57.95 %

Jubilant Pharmova Fundamentals

as on October 1, 2026 at 4:01 pm IST

Market Cap

₹15,918.85 Cr

Return on Equity (ROE)

3.06

PE Ratio (TTM)

44.95

Return on capital employed (ROCE)

1.79

Industry PE ratio

51.84

Beta (LTM)

0.6

P/B Ratio

5.61

Dividend Yield

0.61

PEG Ratio

-6.6

Quarterly Earnings Growth YOY

-44.98

EPS (TTM)

25.16

Book Value

448.91

Jubilant Pharmova Stock Valuation

as on October 1, 2026 at 4:01 pm IST

Jubilant Pharmova in the last 5 years

  • Overview

  • Trends

Lowest (-195.50x)

December 29, 2023

Today (44.95x)

October 1, 2026

Industry (51.84x)

October 1, 2026

Highest (257.22x)

February 16, 2024

LowHigh

Today’s Price to Earnings Ratio: 44.95x

Jubilant Pharmova Technical Analysis

Track how Jubilant Pharmova technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish10
Bullish2
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-1.24
Bearish
CCI (20)
55.23
Neutral
RSI (14)
35.43
Neutral
Momentum (10)
-3.8
Bullish
ADI (14)
31.66
Bearish
Ultimate Oscillator (7,14,28)
32.65
Neutral

Moving Averages

Name

Value

Action

SMA (20)
999.4
Bearish
EMA (20)
998.37
Bearish
VWMA (20)
998.03
Bearish
SMA (50)
1000.14
Bearish
EMA (50)
998.75
Bearish
SMA (200)
996.66
Bearish
EMA (200)
997.54
Bearish
KAMA (200)
1000.01
Bearish
DEMA (200)
995.17
Bullish

Jubilant Pharmova Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jubilant Pharmova with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,918.8511.59%0.733978,279
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD17,266.62-3.19%0.621502,268
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,299.94-6.79%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,998.5036.85%0.682811,703
Poly Medicure Ltd image
Poly Medicure Ltd
BUY16,604.0215.22%0.573201,875
See all

Market expectation of Jubilant Pharmova Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

75.00%

Buy

0.00%

Hold

25.00%

Sell

Jubilant Pharmova Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
1,665.2
1,746.4
1,720.4
1,742.2
1,813.7
1,915.8
1,878.9
1,957.8
2,116.1
2,272.2
2,221.1
Other Income
48.9
17.8
409.9
21.7
9.2
11.9
12
9.8
20.5
23.7
19.9
Total Income
1,726
1,776.4
2,141.6
1,774
1,830.9
1,940.7
1,912.7
1,976.2
2,143
2,313.7
2,249.3
Expenses
1,459.1
1,656.1
1,480.2
1,477.2
1,553.5
1,586.8
1,611.2
1,630.9
1,872.8
1,964.4
1,981.4
Operating Profit
206.1
90.3
240.2
265
260.2
329
267.7
326.9
243.3
307.8
239.7
Operating Profit Margin %
12.38%
5.17%
13.96%
15.21%
14.35%
17.17%
14.25%
16.7%
11.5%
13.55%
10.79%
Profit Before Interest, Tax and Depreciation
266.9
120.3
661.4
296.8
277.4
353.9
301.5
345.3
270.2
349.3
267.9
Interest
71.3
73
71
61
55.6
52.7
49
50.2
56.1
56.5
54.2
Depreciation
94.6
101
90.7
91.4
91.3
95.2
98.1
104.8
120.7
116.8
127.3
Profit Before Tax
101
-53.7
499.7
144.4
130.5
206
154.4
190.3
93.4
176
86.4
Tax Paid
34.6
8.1
17.9
41.9
29.8
54.7
51.9
70.4
37.6
56.7
30
Profit After Tax
66.4
-61.8
481.8
102.5
100.7
151.3
102.5
119.9
55.8
119.3
56.4
Total Net profit including share of profit / Loss from associate company
66.4
-61.8
481.8
102.5
100.7
151.3
102.5
119.9
55.8
119.3
56.4
EPS
4.22
-3.69
30.44
6.47
6.37
9.71
6.49
7.59
3.52
7.55
3.57
Actual EPS
4.22
-3.69
30.44
6.47
6.37
9.71
6.49
7.59
3.52
7.55
3.57
Adjusted EPS
4.22
-3.69
30.44
6.47
6.37
9.71
6.49
7.59
3.52
7.55
3.57
Diluted EPS
4.2
-3.68
30.35
6.46
6.36
9.68
6.47
7.57
3.52
7.52
3.56

Jubilant Pharmova Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
7,424.78
8,997.09
5,842.85
5,963.88
6,059.17
6,219.3
6,644.8
7,192.1
8,225
Other Income
40.03
35.74
257.88
290.64
11.29
50.6
92.8
416.3
66
Total Income
7,557.87
9,146.56
6,233.67
6,389.18
6,141.45
6,332.3
6,795.7
7,650.8
8,345.6
Expenses
5,999.46
7,652.04
4,460.78
4,723.3
4,983.81
5,562.3
5,971
6,061.3
7,079.3
Operating Profit
1,425.32
1,345.05
1,382.07
1,240.58
1,075.36
657
673.8
1,130.8
1,145.7
Operating Profit Margin %
19.2%
14.95%
23.65%
20.8%
17.75%
10.56%
10.14%
15.72%
13.93%
Profit Before Interest, Tax and Depreciation
1,558.41
1,494.52
1,772.89
1,665.88
1,157.64
770
824.7
1,589.5
1,266.3
Interest
284.28
219.81
199.71
184.1
145.49
188.2
272.3
240.3
211.8
Depreciation
415.05
370.9
339.84
348.95
381.7
554
381.9
368.6
440.4
Profit Before Tax
859.08
903.81
1,233.34
1,132.83
630.45
27.8
170.5
980.6
614.1
Tax Paid
224.66
326.8
335.1
297.22
217.43
92.7
97.8
144.3
216.6
Profit After Tax
634.42
577.01
898.24
835.61
413.02
-64.9
72.7
836.3
397.5
Total Net profit including share of profit / Loss from associate company
634.42
577.01
898.24
835.61
413.02
-64.9
72.7
836.3
397.5
EPS
41.25
36.86
56.39
52.48
26
-3.83
4.87
52.99
25.15
Actual EPS
41.25
36.86
56.39
52.48
26
-3.83
4.87
52.99
25.15
Adjusted EPS
35.8
31.99
48.93
52.48
26
-3.83
4.87
52.99
25.15
Diluted EPS
41.25
36.86
56.39
52.48
26
-3.83
4.86
52.85
25.08

Jubilant Pharmova Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,098.89
1,268.49
1,303.2
1,121.51
1,542.94
1,784.27
837.54
660.7
971.3
1,072.1
1,226.8
Cash Flow from Investing Activities
-308.51
-465.43
-614.34
-1,017.72
-267.15
-726.75
-323.08
-473.9
-596.3
512.5
-1,142.9
Cash Flow from Financing Activities
-843.75
-686.09
-901.13
657.42
-1,050.36
-1,709.41
-32.6
-156.7
-432.5
-1,452.7
94.9
Net Cash Flow
-52.37
117.18
-212.27
761.22
225.42
-651.88
481.86
30.1
-57.5
131.9
178.8

Jubilant Pharmova Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
50.68%
50.68%
50.68%
50.68%
50.68%
50.68%
47.68%
47.68%
47.68%
47.68%
47.68%
DII
1.5%
3.78%
4.07%
5.66%
6.98%
7.05%
9.53%
10.52%
11.22%
11.62%
12.4%
FII
0%
19.06%
19.49%
17.94%
16.96%
17.22%
17.4%
16.57%
15.96%
15.9%
15.87%
Public
25.56%
25.9%
25.18%
25.17%
24.83%
24.5%
24.84%
24.6%
24.57%
24.24%
23.5%
Total Outstanding Shares
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
15,92,81,139
Total Shareholders
86,588
92,264
81,992
89,456
1,02,442
96,526
99,673
93,336
90,133
86,347
82,703

Mutual Funds Buying / Exiting Jubilant Pharmova

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Jubilant Pharmova

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan Small Cap Fund Direct Growth

Bandhan Small Cap Fund Direct Growth

₹441.37 Cr

₹20.99 Cr (+4.99%)

1.14%

Bandhan Focused Fund - Direct Plan - Growth

Bandhan Focused Fund - Direct Plan - Growth

₹120.71 Cr

₹5.86 Cr (+5.10%)

5.09%

Mutual Funds Exiting Jubilant Pharmova

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Jubilant Pharmova Corporate Actions

View detailed summary of the earnings and dividend history of Jubilant Pharmova.

  • Jubilant Pharmova Ltd Earnings Results

    Jubilant Pharmova Ltd’s net profit fell -45.09% since last year same period to ₹56.50Cr in the Q1 2026-2027. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -52.68% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Jubilant Pharmova Ltd Dividends May,2026

    In the quarter ending March 2026, Jubilant Pharmova Ltd has declared dividend of ₹5.00 per share on 22 May 2026 - translating a dividend yield of 0.50%.

    Read More about Dividends

Indices Featuring Jubilant Pharmova Stock

Check stock indices that include Jubilant Pharmova.

S&P BSE 250 SmallCap

₹6,909.40

-85.90 (▲1.23%)

S&P BSE 400 MidSmallCap

₹12,074.21

-130.38 (▲1.07%)

BSE 500

₹34,221.41

-342.96 (▲0.99%)

BSE Healthcare

₹49,899.94

-147.16 (▲0.29%)

Insights on Jubilant Pharmova Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.03% to 8.99% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.7% return, outperforming this stock by 67.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.7% return, outperforming this stock by 24.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 47.68% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 24.24% to 23.50% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.31K Cr → 2.24K Cr (in ₹), with an average decrease of 2.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 119.4 Cr → 56.5 Cr (in ₹), with an average decrease of 52.7% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 15.90% to 15.87% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, JUBLPHARMA stock has moved down by -5.8%

About Jubilant Pharmova Ltd

Jubilant Pharmova Ltd is a well-established and leading pharmaceutical company, listed on the Stock Exchange of India. It provides world-class and innovative products and solutions to its customers in the Indian and global markets. It has a sound and strong presence in both the domestic and international markets. The company is focused towards delivering excellent quality healthcare solutions with the highest standards of safety and efficacy. It has implemented stringent quality management systems as well as advanced research and development activities, which enable them to produce quality products meeting all applicable regulatory requirements. With its strong commitment towards delivering excellence, the company takes pride in setting a benchmark in the pharmaceutical industry.

Revenue: ₹2,221.10Cr as on June 2026 (Q1 FY27)
Net Profit: ₹56.40Cr as on June 2026 (Q1 FY27)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
OrganisationJubilant Pharmova Ltd
HeadquartersNoida
IndustryPharmaceuticals
CEOShyam S Bhartia
E-voting on sharesClick here to vote

FAQs

What is Jubilant Pharmova share price today?

Jubilant Pharmova share price today stands at ₹999.3 as on at the close of the market. Jubilant Pharmova share today touched a day high of ₹1028.6 and a low of ₹980.3.

What is the 52 week high and 52 week low range for Jubilant Pharmova share?

Jubilant Pharmova touched a 52 week high of ₹1184.8 and a 52 week low of ₹786.05. Jubilant Pharmova share price today i.e. is closed at ₹999.3, which is -15.66% down from its 52 week high and 27.13% up from its 52 week low.

What is Jubilant Pharmova's market capitalisation today?

Jubilant Pharmova market capitalisation is ₹15,918.85 Cr as on .

How to buy Jubilant Pharmova shares?

To buy Jubilant Pharmova shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for JUBLPHARMA or Jubilant Pharmova Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Jubilant Pharmova shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Jubilant Pharmova trading volume today?

Jubilant Pharmova trading volume is 3.36L as on . This means that 3.36L shares of Jubilant Pharmova were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Jubilant Pharmova shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Jubilant Pharmova have both increased over the past 30 days, and the average INDmoney investor holds the stock for 36 days. This reflects platform activity only and is not investment advice.